Wide-bandgap power semiconductors have become one of the most strategically important and most litigated areas in electronics, and their patent landscape is distinctive because value and risk are spread across the full stack from crystal to module. Silicon carbide and gallium nitride switch faster, tolerate higher voltages and temperatures, and lose less energy than conventional silicon, which is why they are central to electric-vehicle drivetrains, fast charging, solar and grid power conversion, and the power delivery of AI data centers; peer-reviewed reviews document these comparative properties and the trade-offs between the two materials.¹,² The intellectual property divides across several regions, each with different owners and maturity: the substrate and bulk-crystal growth that produces the raw material; the epitaxy that grows the active layers, including gallium nitride on silicon; the device design, such as the transistor and diode structures, whose failure and reliability modes are a distinct engineering concern;³ the packaging and thermal-management technologies that manage heat and switching losses;² and the application-level integration into drivetrains and power systems, where gallium-nitride high-electron-mobility transistors are increasingly used.⁴ Because a competitive product depends on several of these layers, freedom-to-operate is a multi-layer analysis rather than a single clearance.

The landscape is defined by intense litigation. Established wide-bandgap developers with deep substrate and device portfolios have asserted their patents against newer entrants, and the disputes have moved through trade-enforcement bodies and the federal courts. In a US International Trade Commission investigation into certain semiconductor devices, a final initial determination issued on December 2, 2025 found a violation as to one asserted patent and no violation as to a second, with the Commission determining to review the decision in part, a proceeding that remained under Commission review as of early 2026.⁶ In parallel, a wide-bandgap developer has asserted foundational gallium-nitride and silicon-carbide patents against a competitor in US federal court, with the case active on the district-court docket.⁷ Parallel proceedings are underway in other jurisdictions. This pattern signals a maturing field in which foundational substrate, epitaxy, and device patents create real barriers, and in which a single infringement finding in a key market can reshape a competitor's access to it. The ownership picture is concentrated but contested: across the Cypris corpus of more than 500 million patents and scientific papers, the most active assignees in the gallium-nitride power-device set are incumbent integrated device manufacturers, led by Japanese and European firms such as Mitsubishi Electric, Fuji Electric, Infineon, Toshiba, and Rohm, together with foundries and a small number of US developers, of which one substrate-and-device specialist is the clearest pure-play; the set holds on the order of 80,000 families on an indicative basis and grew roughly 2.4 times between 2018 and 2024, with China and the United States leading on assignee geography, followed by Japan, Germany, and South Korea. Because applications publish about eighteen months after filing, the most recent device and packaging filings are under-represented (2025 counts are partial), so the current frontier is more active than granted-patent counts suggest.

The strategic question is which layer to own, and the answer differs by material. In silicon carbide, the substrate and bulk-crystal layer is a durable barrier because high-quality crystal growth is difficult and capital-intensive, so much of the defensible value sits upstream. In gallium nitride, where devices are often grown on silicon wafers, the contested ground is more in epitaxy, device architecture, and packaging, and the litigation has concentrated there. Across both, packaging and thermal management are rising in importance as switching speeds increase,² and ultra-wide-bandgap approaches are an emerging frontier beyond today's materials.⁵ Reading the landscape by material, layer, and owner, and tracking the live proceedings, is what separates a workable position from a blocked one.

What creates FTO risk in wide-bandgap power semiconductors

Substrate and crystal-growth claims. These cover bulk silicon-carbide crystal and wafer production, a capital-intensive, upstream layer that is a durable barrier in silicon carbide.

Epitaxy claims. These cover the growth of active layers, including gallium nitride on silicon, a heavily contested layer central to gallium-nitride litigation.

Device-design claims. These cover transistor and diode structures and their edge terminations and gate designs, whose reliability and failure modes are a frequent center of disputes.³

Packaging and module claims. These cover thermal management, interconnection, and module construction, a layer rising in importance as switching speeds increase.²

Application-integration claims. These cover integration into drivetrains, chargers, and power systems, so a device can be free at the component level and constrained in a specific application.⁴

How AI-powered landscape and FTO analysis helps

A multi-layer, cross-border, heavily litigated landscape is beyond manual clearance. AI-powered analysis addresses this with semantic search that retrieves relevant substrate, epitaxy, device, and packaging claims regardless of terminology, attribution that normalizes incumbent and challenger owners to canonical entities across jurisdictions, claim-level analysis that separates the layers, and continuous monitoring that tracks new filings and the live disputes. Because wide-bandgap advances appear in scientific literature before they are patented, reading both patents and literature gives earlier warning of where the field is extending.

Where Cypris fits

Cypris runs patent landscape and freedom-to-operate analysis for multi-layer, litigated fields such as wide-bandgap power semiconductors across a corpus of more than 500 million patents and scientific papers, organized through a proprietary R&D ontology. The ontology clusters the landscape by material and layer, substrate, epitaxy, device, packaging, and application, and normalizes owners to canonical entities across jurisdictions, so a team sees how rights are distributed between incumbents and challengers rather than a flat list. Semantic search across patents and scientific literature surfaces relevant claims regardless of terminology and connects filings to the underlying materials and device research, which is where next-generation structures emerge first. Cypris Q, the platform's agentic layer, lets teams run landscape and FTO analysis conversationally and chain the attribution, clustering, and claim-level analysis across layers, and Agentic Monitoring tracks the landscape over time and flags new filings and developments as they publish. Cypris provides enterprise API partnerships with OpenAI, Anthropic, and Google, and is built with enterprise-grade security. Cypris serves hundreds of enterprise customers across pharmaceuticals, chemicals, advanced materials, energy, and other regulated industries.

FAQ

Why are wide-bandgap power semiconductors a patent hotspot? Wide-bandgap power semiconductors are a patent hotspot because silicon carbide and gallium nitride enable more efficient power electronics for electric vehicles, fast charging, renewables, and AI data centers, creating a large and fast-growing market. Value and risk are spread across substrate, epitaxy, device, and packaging layers. That breadth, plus intense competition, has produced heavy litigation.

What layers does the SiC and GaN landscape cover? The landscape covers substrate and bulk-crystal growth, epitaxy, device design, packaging and modules, and application integration. In silicon carbide the substrate layer is a durable upstream barrier, while in gallium nitride the contested ground is more in epitaxy, device design, and packaging. Freedom-to-operate must span the relevant layers for each material.

Why is this field so heavily litigated? The field is heavily litigated because foundational substrate, epitaxy, and device patents create real barriers, incumbents hold deep portfolios, and fast-growing challengers are building their own. Disputes have moved through the US International Trade Commission and the federal courts, with a December 2025 ITC determination finding a violation as to one patent and none as to another, and a separate district-court case over foundational gallium-nitride and silicon-carbide patents. A single ruling in a key market can reshape competitive access.

Where is the white space in wide-bandgap semiconductors? The white space includes packaging and thermal management as switching speeds rise, device architectures that design around crowded structures, gallium-nitride epitaxy and integration approaches, and application-level integration into drivetrains and power systems. The silicon-carbide substrate layer is a durable barrier held by incumbents. The higher-value opportunities are in packaging, device design, and integration.

How do silicon carbide and gallium nitride differ in the patent picture? They differ because silicon carbide value concentrates upstream, in difficult, capital-intensive crystal growth, while gallium nitride, often grown on silicon, concentrates contested IP in epitaxy, device architecture, and packaging. The litigation patterns reflect this. Freedom-to-operate strategy should therefore be tailored to the material.

Why does wide-bandgap analysis need scientific literature? Wide-bandgap analysis needs scientific literature because materials, device, and packaging advances appear in research before they are patented, so the literature gives the earliest signal. Analyzing patents alone gives a lagging view. Cypris analyzes both across more than 500 million patents and scientific papers.

What software helps analyze the SiC and GaN patent landscape? Software for the wide-bandgap landscape should cluster activity by material and layer, resolve incumbent and challenger owners to canonical entities across jurisdictions, search patents and scientific literature semantically, and monitor active litigation and new filings continuously. Cypris does this across more than 500 million patents and scientific papers using a proprietary R&D ontology, semantic search, Cypris Q, and Agentic Monitoring.

Which teams use wide-bandgap patent landscape analysis? Wide-bandgap patent landscape analysis is used by R&D, IP, and strategy teams at semiconductor, automotive, power-electronics, and energy companies, as well as investors assessing the sector. Because the field is litigated across the full stack and across borders, structured analysis is essential. Cypris serves hundreds of enterprise customers across advanced materials, energy, and other research-intensive industries.

Endnotes

1. Stanley, C., Herzog, S., Viewegh, M., Biggerstaff, T., et al. (2026). Wide bandgap semiconductors for power electronics: comparative properties, applications, and reliability of GaN and SiC devices. Hardware, 4(1). https://doi.org/10.3390/hardware4010006
2. Kim, J., Bae, S., Han, S., & Park, S. (2025). Thermal management of wide-bandgap power semiconductors: strategies and challenges in SiC and GaN power devices. Electronics, 14(21), 4193. https://doi.org/10.3390/electronics14214193
3. Romano, G., Imburgia, A., Ala, G., Rizzo, G., et al. (2025). Comprehensive review of wide-bandgap devices: SiC MOSFET and its failure modes affecting reliability. Physchem, 5(1). https://doi.org/10.3390/physchem5010010
4. Rusli, M., Jarndal, A., & Hamza, K. H. (2026). GaN HEMTs for electric vehicle power electronics: device architectures, reliability and next-generation wide-bandgap opportunities. Energies, 19(7), 1752. https://doi.org/10.3390/en19071752
5. Adekunle, A. (2025). Review of ultra wide bandgap GaN-based HEMTs for high-efficiency power conversion. International Journal of Future Engineering Innovations, 2(3). https://doi.org/10.54660/ijfei.2025.2.3.77-83
6. U.S. International Trade Commission. Certain semiconductor devices and products containing the same, Investigation No. 337-TA-1414 (Final Initial Determination, Dec. 2, 2025; Commission review in part). Federal Register / public-inspection record. https://public-inspection.federalregister.gov/2026-02297.pdf
7. Wolfspeed, Inc. v. Navitas Semiconductor Corporation, U.S. District Court for the District of Delaware, No. 1:24-cv-01038 (docket). https://www.courtlistener.com/docket/69457003/parties/wolfspeed-inc-v-navitas-semiconductor-corporation

‍

Small modular reactors and advanced nuclear designs have moved from concept toward licensing and deployment, and their patent landscape is distinctive because it spans several competing reactor families and a fuel supply chain that must be built alongside them. Where conventional nuclear plants are large, bespoke, and light-water-cooled, SMRs and advanced reactors are smaller, factory-built, and often use novel coolants, moderators, and fuels to achieve passive safety and flexible operation. The field divides into distinct regions of patenting: the reactor concepts themselves, including high-temperature gas-cooled reactors, molten-salt reactors, sodium-cooled fast reactors, integral light-water SMRs, and microreactors; the core, coolant, and moderator designs within each, from tristructural isotropic coated-particle fuel in gas-cooled reactors to fluoride fuel salts in molten-salt reactors;¹,²,³ the advanced fuels, especially TRISO particles and the high-assay low-enriched uranium, or HALEU, they require; the passive safety systems and control approaches that shut a reactor down without active intervention;⁵,⁶ and the modular manufacturing and construction methods that make factory production possible.⁴ Alongside these sit non-electric applications, from industrial heat and hydrogen to powering data centers. Because a viable design depends on several of these layers, and on a fuel supply that does not yet exist at scale, freedom-to-operate and white space analysis must span reactor, fuel, and manufacturing together.

The landscape is being reshaped by licensing progress and by a surge in demand. Regulators have modernized the framework for licensing advanced reactors, adopting a risk-informed, performance-based, and technology-inclusive rule intended to accommodate the range of SMR and advanced designs,⁷ while government programs are standing up a domestic supply of HALEU, the enriched fuel that many advanced reactors need and that has not been commercially produced at scale. Demand has accelerated sharply as technology companies contract for nuclear power to run data centers, drawing large investment. The competitive picture spans reactor developers pursuing different coolant and fuel choices, specialized fuel fabricators building TRISO and HALEU capacity, and established nuclear suppliers. This shows in the record: across the Cypris corpus of more than 500 million patents and scientific papers, the nuclear-anchored SMR, microreactor, TRISO, molten-salt, and HALEU set holds on the order of 2,017 families and grew from about 87 in 2020 to roughly 250 in 2024, with the most active assignees mixing large academic and institutional filers, led by Chinese universities and institutes, with reactor developers and fuel fabricators such as TerraPower, Mitsubishi Heavy Industries, BWXT, and Westinghouse and the US Department of Energy, and China ahead of the United States and South Korea on geography; a broad, unfiltered "microreactor" query returns far more families but is contaminated by unrelated chemical-microreactor art, so the nuclear-anchored figure is the defensible one. Because applications publish about eighteen months after filing, the most recent reactor and fuel filings are under-represented (2025 and 2026 counts are partial), so the current frontier is more active than granted-patent counts suggest.

The strategic question is which reactor family and layer to back, and the white space sits where technology and supply chain intersect. Advanced fuel, TRISO fabrication and the HALEU supply chain, is a critical, comparatively concentrated layer where scaling and cost are the barriers, so fabrication methods and fuel designs carry high value.¹ Coolant and materials that survive high temperatures and long fuel cycles, across gas, salt, and metal-cooled designs, passive safety systems, modular manufacturing and construction that lower cost and schedule, and non-electric applications such as process heat, hydrogen, and dispatchable power for data centers are all distinct, contested layers.²,³ Reading the landscape by reactor family, layer, and owner, and tracking both the patents and the underlying nuclear-engineering research, is what separates a crowded region from an open one.

Where the advanced-nuclear white space is

Advanced fuel and HALEU supply. TRISO fabrication methods and the high-assay low-enriched uranium supply chain are a critical, concentrated layer where scaling and cost are the barriers.¹

Coolant, moderator, and materials. Coolants and materials that survive high temperatures and long fuel cycles, across gas, salt, and metal-cooled designs, are a distinct, high-value layer.²,³

Passive safety systems. Systems and control approaches that shut a reactor down without active intervention are a differentiating capability central to SMR value.⁵,⁶

Modular manufacturing and construction. Factory-built modules and construction methods that lower cost and schedule are where the economic case is decided.⁴

Non-electric applications. Industrial heat, hydrogen production, and dispatchable power for data centers open distinct application and integration IP.

How AI-powered landscape and white space analysis helps

Resolving a landscape that spans several reactor families, a fuel supply chain, and manufacturing requires more than keyword search. AI-powered analysis addresses this with semantic search that clusters activity by reactor family, layer, and application across varied terminology, attribution that normalizes developer, fuel-fabricator, and supplier filers to canonical entities, and continuous monitoring that keeps pace with a fast-moving field. Because nuclear advances appear in scientific and engineering literature before they are patented, reading both patents and literature gives the earliest signal of where the frontier is moving.

Where Cypris fits

Cypris runs patent landscape and white space analysis for engineering-intensive fields such as small modular reactors and advanced nuclear across a corpus of more than 500 million patents and scientific papers, organized through a proprietary R&D ontology. The ontology clusters activity by reactor family, gas-cooled, molten-salt, sodium-cooled, light-water, and microreactor, and by layer, reactor design, advanced fuel, passive safety, and manufacturing, and normalizes developer, fuel-fabricator, and supplier filers to canonical entities, so a team can resolve which families and layers are crowded and which remain open as white space, and can separate genuine advanced-nuclear filings from unrelated art that shares terminology. Semantic search across patents and scientific literature connects filings to the underlying nuclear-engineering research, which is where advances appear first. Cypris Q, the platform's agentic layer, lets teams run landscape and white space analysis conversationally and chain the clustering, attribution, and gap analysis, and Agentic Monitoring tracks a defined family over time and flags new patents and papers as they publish. Cypris provides enterprise API partnerships with OpenAI, Anthropic, and Google, and is built with enterprise-grade security. Cypris serves hundreds of enterprise customers across pharmaceuticals, chemicals, advanced materials, energy, and other regulated industries.

FAQ

What is the small modular reactor patent landscape? The small modular reactor patent landscape is the set of patents covering factory-built, smaller nuclear reactors and advanced designs. It spans reactor families, high-temperature gas-cooled, molten-salt, sodium-cooled fast, light-water, and microreactors, plus advanced fuels, passive safety, and modular manufacturing. Each is a distinct region of patenting.

What are the main advanced reactor families? The main families are high-temperature gas-cooled reactors, molten-salt reactors, sodium-cooled fast reactors, integral light-water SMRs, and microreactors. They differ in coolant, moderator, fuel, and operating temperature. The choice of family shapes both the technical and the freedom-to-operate picture.

Why are TRISO and HALEU fuels important? TRISO and HALEU fuels are important because many advanced reactors depend on TRISO coated particles, which resist very high temperatures, and on high-assay low-enriched uranium, which is not yet commercially produced at scale. Building this fuel supply chain is a critical enabler. Fabrication methods and fuel designs are therefore a concentrated, high-value layer.

Why is data-center demand accelerating advanced nuclear? Data-center demand is accelerating advanced nuclear because technology companies need large amounts of reliable, carbon-free power, and have begun contracting for SMR and advanced-reactor output. This has drawn substantial investment and sharpened competition. It has also expanded interest in non-electric and dispatchable applications.

How does advanced-reactor licensing work? Advanced-reactor licensing in the United States distinguishes several steps, including design approval or certification, a construction permit, and an operating license, and regulators have adopted a modernized, risk-informed, technology-inclusive framework to accommodate advanced designs. A construction permit is not an operating license. Claims about a given project's status should be tied to the specific regulatory record.

Where is the white space in advanced nuclear? The white space includes advanced fuel and HALEU supply, coolant, moderator, and materials, passive safety systems, modular manufacturing and construction, and non-electric applications. The reactor-design and fuel layers are the most active. The most open, high-value opportunities are in fuel, materials, and manufacturing.

What software helps analyze the small modular reactor patent landscape? Software for the advanced-nuclear landscape should cluster activity by reactor family, layer, and application, resolve developer, fuel-fabricator, and supplier filers to canonical owners, separate genuine advanced-nuclear filings from unrelated art, search patents and scientific literature semantically, and monitor a fast-moving field continuously. Cypris does this across more than 500 million patents and scientific papers using a proprietary R&D ontology, semantic search, Cypris Q, and Agentic Monitoring.

Which teams use advanced-nuclear patent landscape analysis? Advanced-nuclear patent landscape analysis is used by R&D, IP, and strategy teams at reactor developers, fuel fabricators, nuclear suppliers, utilities, and technology buyers, as well as investors assessing the sector. Because the field spans reactor, fuel, and manufacturing layers, structured analysis is essential. Cypris serves hundreds of enterprise customers across energy and other research-intensive industries.

Endnotes

1. International Atomic Energy Agency (2025). Coated particle fuels for high-temperature gas-cooled small modular reactors. https://doi.org/10.61092/iaea.zyya-k9sd
2. Powers, J. J., & Gehin, J. C. (2016). Liquid-fuel molten salt reactors for thorium utilization. Nuclear Technology, 194(2). https://doi.org/10.13182/nt15-124
3. Grimes, W. R. (1970). Molten-salt reactor chemistry. Nuclear Applications and Technology, 8(2). https://doi.org/10.13182/nt70-a28621
4. Hannah, B. (2026). Technical assessment of molten salt reactor small modular reactors: design and licensing considerations. https://doi.org/10.5281/zenodo.20087242
5. Zarei, M. (2020). State feedback control of power in a small modular reactor. Annals of Nuclear Energy, 144. https://doi.org/10.1016/j.anucene.2020.107743
6. Diniz, R., et al. (2023). Reactivity calculation in molten salt reactors with an inverse kinetics model. Annals of Nuclear Energy, 190. https://doi.org/10.1016/j.anucene.2023.110130
7. U.S. Nuclear Regulatory Commission (2026). 10 CFR Part 53 — risk-informed, technology-inclusive regulatory framework for advanced nuclear reactors (final rule). https://www.ecfr.gov/current/title-10/chapter-I/part-53

Perovskite-silicon tandem solar cells are the leading path to higher photovoltaic efficiency, and their patent landscape has become unusually central to competition because the field is commercializing through licensing as much as through manufacturing. A tandem cell places a wide-bandgap perovskite layer on top of a conventional silicon cell, so the two absorb different parts of the solar spectrum and the stack converts more sunlight than either alone, surpassing the single-junction limit that constrains standard silicon.¹,² The theoretical ceiling for a silicon-based tandem is about 43.2 percent, far above the roughly 33 percent limit of a single-junction silicon cell, which is what makes the architecture so attractive.³ The intellectual property divides across several regions, each with different owners and maturity: the perovskite compositions and their stability chemistry; the passivation and interface layers that raise efficiency and lifetime; the tandem device architecture, including the recombination layers that join the sub-cells; the texturing and deposition processes used to build the stack; and the encapsulation and manufacturing that make a durable module. Because a working tandem depends on all of these, freedom-to-operate and white space analysis must span the full stack.

The landscape is being shaped by patents and cross-licensing in real time. Certified efficiencies have climbed steeply: the current certified perovskite/silicon tandem record stands at 34.85 percent, achieved by LONGi and certified by the US National Renewable Energy Laboratory in 2025, and peer-reviewed work now describes certified perovskite/silicon efficiencies approaching 35 percent, with the live record register maintained on the NREL Best Research-Cell Efficiency Chart.⁴,⁵,⁶ These are laboratory cell records rather than commercial-module ratings, and translating them to industry-compatible cells and full modules is a distinct challenge the field is actively working through.¹⁰ Multi-junction routes are advancing in parallel, with triple-junction perovskite/perovskite/silicon devices exceeding 30 percent.⁷ Holders of strong foundational portfolios have begun licensing their technology to large manufacturers, signaling that IP position, not only manufacturing capacity, will determine who benefits from the transition. That structure is visible in the patent record: across the Cypris corpus of more than 500 million patents and scientific papers, the perovskite-tandem space is a comparatively small, fast-moving set of a few thousand de-duplicated families that stepped up sharply in 2025, and its most active assignees mix national laboratories such as CEA and CNRS, the perovskite specialist Oxford PV, and large silicon-module manufacturers, with China, the United States, South Korea, and France the leading jurisdictions; because assignee names are not fully canonicalized, manufacturer totals are best read as indicative. Because applications publish about eighteen months after filing, the most recent composition and process filings are under-represented, so the current frontier is more active than granted-patent counts suggest.

The strategic question is which layer to own, and the white space sits where durability is hardest to achieve. Perovskite stability under heat, humidity, and light remains the central unsolved problem, and the degradation mechanisms and stabilization techniques that address it are an area of intense, well-mapped research,⁸ as are the barrier and encapsulation designs that protect the cell over its service life.⁹ Compositions, passivation chemistries, and encapsulation that extend lifetime therefore carry high, defensible value, while tandem architecture and light-management texturing are contested and improving quickly, and scalable deposition and manufacturing are where laboratory records must survive the move to gigawatt production. Reading the landscape by composition, layer, and process, and tracking both the patents and the underlying materials research, is what separates a crowded region from an open one.

Where the perovskite tandem white space is

Stability and encapsulation. Compositions, passivation, and encapsulation that keep efficiency under heat, humidity, and light are the central unsolved problem and the highest-value, still-open target.⁸,⁹

Wide-bandgap perovskite compositions. Formulations tuned for the top cell that resist phase segregation are a contested, fast-moving composition layer.

Tandem architecture. Recombination layers, interconnection, and two-terminal versus four-terminal designs are a distinct device-engineering layer.⁷

Texturing and light management. Surface texturing and optical designs that maximize capture across the stack are an active process-IP area.

Scalable deposition and manufacturing. Moving high-efficiency processes from small cells to gigawatt-scale modules is where cost is decided and where durable process IP concentrates.¹⁰

How AI-powered landscape and white space analysis helps

Resolving a device landscape that spans compositions, interface and architecture layers, and manufacturing processes, across institutions and regions moving at different speeds, requires more than keyword search. AI-powered analysis addresses this with semantic search that clusters activity by layer and process across varied terminology, attribution that normalizes academic and commercial filers to canonical entities and tracks the licensing structure, and continuous monitoring that keeps pace with a fast-commercializing field. Because perovskite advances appear in scientific literature before they are patented, reading both patents and literature gives the earliest signal of where the frontier is moving.

Where Cypris fits

Cypris runs patent landscape and white space analysis for fast-commercializing energy fields such as perovskite tandem solar across a corpus of more than 500 million patents and scientific papers, organized through a proprietary R&D ontology. The ontology clusters activity by layer, perovskite composition, passivation and interfaces, tandem architecture, texturing and deposition, and encapsulation and manufacturing, and normalizes filers to canonical entities, so a team can resolve which layers are crowded and which remain open as white space, and can see the licensing structure clearly rather than as a flat list. Semantic search across patents and scientific literature connects filings to the underlying materials and device research, which is where perovskite advances appear first. Cypris Q, the platform's agentic layer, lets teams run landscape and white space analysis conversationally and chain the clustering, attribution, and gap analysis, and Agentic Monitoring tracks a defined layer over time and flags new patents and papers as they publish. Cypris provides enterprise API partnerships with OpenAI, Anthropic, and Google, and is built with enterprise-grade security. Cypris serves hundreds of enterprise customers across pharmaceuticals, chemicals, advanced materials, energy, and other regulated industries.

FAQ

What is the perovskite tandem solar patent landscape? The perovskite tandem solar patent landscape is the set of patents covering perovskite-silicon and all-perovskite tandem cells that exceed the single-junction efficiency limit. It divides across perovskite compositions and stability, passivation and interfaces, tandem architecture, texturing and deposition, and encapsulation and manufacturing. Each is a distinct region with different owners and maturity.

Why is IP so central to perovskite tandem solar? IP is central because the field is commercializing through licensing as much as through manufacturing, with holders of strong foundational portfolios licensing their technology to large manufacturers. Foundational process and architecture patents are concentrated among a few institutions and companies. That makes licensing and freedom-to-operate, not only production capacity, decisive.

What layers does the perovskite tandem landscape cover? The landscape covers perovskite composition and stability chemistry, passivation and interface layers, tandem device architecture including recombination layers, texturing and deposition processes, and encapsulation and manufacturing. A working tandem depends on all of them. Freedom-to-operate and white space analysis must span the full stack.

Where is the white space in perovskite tandem solar? The white space sits where durability is hardest: stability and encapsulation, wide-bandgap compositions that resist phase segregation, tandem architecture, light-management texturing, and scalable deposition. Stability under heat, humidity, and light is the central unsolved problem. The highest-value, most defensible positions are in lifetime and manufacturability.

Why is stability the key problem in the patent record? Stability is the key problem because perovskites can degrade under heat, humidity, and light, so the compositions, passivation, and encapsulation that extend lifetime are where the most valuable and defensible IP concentrates. Efficiency records matter, but durable modules require solving stability. The patent record reflects intense activity in these layers.

Why does perovskite analysis need scientific literature? Perovskite analysis needs scientific literature because new compositions, passivation chemistries, and device architectures appear in materials research before they are patented, so the literature gives the earliest signal. Analyzing patents alone gives a lagging view. Cypris analyzes both across more than 500 million patents and scientific papers.

What software helps analyze the perovskite tandem solar patent landscape? Software for the perovskite tandem landscape should cluster activity by device layer and process, resolve academic and commercial filers and the licensing structure to canonical owners, search patents and scientific literature semantically, and monitor a fast-commercializing field continuously. Cypris does this across more than 500 million patents and scientific papers using a proprietary R&D ontology, semantic search, Cypris Q, and Agentic Monitoring.

Which teams use perovskite tandem patent landscape analysis? Perovskite tandem patent landscape analysis is used by R&D, innovation, IP, and strategy teams at solar manufacturers, materials developers, and equipment makers, as well as investors and research institutions. It informs which layer to back, where to file, where to license, and where competitors are concentrated. Cypris serves hundreds of enterprise customers across energy, advanced materials, chemicals, and other regulated industries.

Endnotes

1. Zhang, F., Shi, Y., & Berry, J. J. (2024). Perovskite/silicon tandem solar cells: insights and outlooks. ACS Energy Letters, 9(4). https://doi.org/10.1021/acsenergylett.4c00172
2. Zheng, X., Tan, H., et al. (2023). Efficient perovskite/silicon tandem solar cells on industrially compatible textured silicon. Advanced Materials, 35(10). https://doi.org/10.1002/adma.202207883
3. Schubert, M. C., Glunz, S. W., et al. (2025). Elucidating the efficiency limit of silicon-based monolithic tandem cells through the combination of Auger and Shockley-Queisser limits. EES Solar. https://doi.org/10.1039/d5el00085h
4. Chen, W., Mularso, K. T., Jung, H. S., & Jo, B., et al. (2026). Strategies toward maximizing power conversion efficiency in all-perovskite tandem solar cells. Solar RRL. https://doi.org/10.1002/solr.202500911
5. LONGi (2025, April 16). LONGi breaks world record for crystalline silicon-perovskite tandem solar cell efficiency (34.85%). https://www.longi.com/en/news/silicon-perovskite-tandem-solar-cells-new-world-efficiency
6. National Renewable Energy Laboratory. Best research-cell efficiency chart. https://www.nrel.gov/pv/cell-efficiency
7. Aydin, E., Xu, L., De Wolf, S., et al. (2024). Four-terminal perovskite/perovskite/silicon triple-junction tandem solar cells with over 30% power conversion efficiency. ACS Energy Letters, 9(8). https://doi.org/10.1021/acsenergylett.4c01292
8. Ahn, N., & Choi, M. (2023). Towards long-term stable perovskite solar cells: degradation mechanisms and stabilization techniques. Advanced Science, 10(35). https://doi.org/10.1002/advs.202306110
9. Yang, Z., Liu, Z., Chen, W., et al. (2020). Barrier designs in perovskite solar cells for long-term stability. Advanced Energy Materials, 10(26). https://doi.org/10.1002/aenm.202001610
10. Jost, M., et al. (2021). 27.9% efficient monolithic perovskite/silicon tandem solar cells on industry-compatible bottom cells. Solar RRL, 5(6). https://doi.org/10.1002/solr.202100244

‍

Metal-organic frameworks have moved from a laboratory curiosity to a commercial materials platform, and their patent landscape is being staked out just as the field reaches scale. A MOF is a porous crystalline material built by linking metal nodes with organic linkers into an ordered framework, producing extraordinarily high surface areas and pores that can be tuned for a target molecule; more than 20,000 distinct MOFs had already been reported by the early 2010s, and the reticular chemistry behind them has continued to mature.¹,² Recognition by the 2025 Nobel Prize in Chemistry, awarded to Susumu Kitagawa, Richard Robson, and Omar Yaghi for the development of metal-organic frameworks, underscored the field's arrival and named applications from carbon-dioxide capture and toxic-gas storage to water harvesting, catalysis, and the separation of per- and polyfluoroalkyl substances from water.³ The intellectual property now divides across three broad regions: the specific framework compositions and structures themselves; the synthesis, shaping, and manufacturing processes that turn a powder into a usable, scalable product; and the application-level systems that integrate a MOF into a working device. Because MOFs serve many functions, freedom-to-operate and white space analysis must span all of them.

The commercial tipping point is reshaping the patent picture. After years in which scale-up and cost were the barriers, industrial-scale production of MOFs for carbon capture has begun, and a wave of startups is pursuing modular capture systems that are easier to scale than incumbent solvent processes, alongside chemical majors moving into manufacturing. Direct air capture of carbon dioxide has been demonstrated in purpose-designed frameworks from the laboratory through pilot scale, distinct from higher-concentration point-source capture.⁶ The scale of activity is large: across the Cypris corpus of more than 500 million patents and scientific papers, the MOF and reticular-chemistry space holds well over 100,000 de-duplicated families and has sustained high-volume filing since around 2018, with the assignee base led by academic institutions and chemical majors such as Sinopec, BASF, and ExxonMobil also prominent, while China accounts for the large majority of families, ahead of the United States, Japan, Germany, and South Korea. This shift moves value from the bare framework composition, where foundational academic estates are concentrated, toward the synthesis, shaping, and system-integration layers. Because applications publish about eighteen months after filing, the most recent synthesis and application filings are under-represented, so the current frontier is more active than granted-patent counts suggest.

The landscape divides by application, and the white space sits where a MOF must survive real conditions at low cost. Water stability, cycling durability, and inexpensive, scalable synthesis are the recurring bottlenecks; the criteria for a high-performance water-adsorbing framework, pore size and shape, hydrophilicity, and stability, are well defined but hard to meet at once.⁴ Carbon capture, both point-source and direct air capture, is the most active application and the one drawing the most new entrants; gas separation, increasingly through mixed-matrix membranes,⁷ and gas adsorption and storage⁸ are established; atmospheric water harvesting has advanced from concept toward passive devices,⁵ and newer uses such as direct lithium extraction and contaminant removal are earlier and less crowded. Underlying all of them is the reticular-design principle that lets chemists build frameworks to order for a target function.⁹ Reading the landscape by composition, synthesis route, and application is what separates a crowded region from an open one.

Where the MOF white space is

Water-stable, low-cost frameworks. MOFs that keep performance under humidity and real operating conditions, made by inexpensive routes, are the central bottleneck and a high-value, still-open target.⁴

Scalable synthesis and shaping. Converting powders into pellets, monoliths, and coatings by manufacturable processes is where deployment is decided and where hard-to-design-around process IP concentrates.

Direct air capture sorbents. MOFs tuned for capturing dilute atmospheric carbon dioxide are an active, high-value frontier distinct from point-source capture.⁶

Non-carbon separations. Direct lithium extraction, contaminant and per- and polyfluoroalkyl-substance removal, and other selective separations are earlier and less crowded application layers.

System integration. Contactors, modules, and regeneration systems that turn a MOF into a working unit are a distinct engineering layer separate from the framework chemistry.

How AI-powered landscape and white space analysis helps

Resolving a materials platform that spans many framework chemistries, synthesis routes, and application areas requires more than keyword search. AI-powered analysis addresses this with semantic search that clusters activity by composition, synthesis route, and application across varied terminology, attribution that normalizes academic and commercial filers to canonical entities and tracks new entrants, and continuous monitoring that keeps pace with a field reaching commercial scale. Because MOF advances appear in scientific literature before they are patented, reading both patents and literature gives the earliest signal of where deployable materials are emerging.

Where Cypris fits

Cypris runs patent landscape and white space analysis for materials platforms such as metal-organic frameworks across a corpus of more than 500 million patents and scientific papers, organized through a proprietary R&D ontology. The ontology clusters activity by framework composition, by synthesis and shaping route, and by application, carbon capture, gas separation and storage, water harvesting, catalysis, and mineral recovery, and normalizes filers to canonical entities, so a team can resolve which compositions, routes, and applications are crowded and which remain open as white space, and can track new entrants as the field scales. Semantic search across patents and scientific literature connects filings to the underlying materials chemistry research, which is where MOF advances appear first. Cypris Q, the platform's agentic layer, lets teams run landscape and white space analysis conversationally and chain the clustering, attribution, and gap analysis, and Agentic Monitoring tracks a defined application over time and flags new patents and papers as they publish. Cypris provides enterprise API partnerships with OpenAI, Anthropic, and Google, and is built with enterprise-grade security. Cypris serves hundreds of enterprise customers across pharmaceuticals, chemicals, advanced materials, energy, and other regulated industries.

FAQ

What is the metal-organic framework patent landscape? The metal-organic framework patent landscape is the set of patents covering MOFs, porous crystalline materials built from metal nodes and organic linkers, and their uses. It divides across framework compositions, synthesis and shaping processes, and application-level systems. Each application, from carbon capture to gas storage, is a distinct region of the landscape.

Why are MOFs a patenting hotspot now? MOFs are a patenting hotspot now because the field has reached a commercial tipping point, with industrial-scale production beginning for carbon capture and a wave of startups pursuing modular systems. Recognition by the 2025 Nobel Prize in Chemistry has further raised the field's profile. That shift is concentrating new filings in synthesis and application layers.

What application areas does the MOF landscape cover? The MOF landscape covers carbon capture from flue gas and directly from air, gas separation and storage, water harvesting, catalysis, sensing, drug delivery, and recovery of critical minerals such as lithium. Each demands different framework and system properties. Freedom-to-operate and white space analysis must span all of them.

Where is the white space in MOFs? The white space sits where a MOF must survive real conditions cheaply: water-stable, low-cost frameworks and scalable synthesis and shaping are the central bottlenecks, and direct air capture sorbents, non-carbon separations, and system integration are less crowded. The bare framework composition is where foundational estates concentrate. The higher-value opportunities are in deployability.

How is MOF value shifting from composition to manufacturing? MOF value is shifting because, as the field scales, the barrier moves from discovering a framework to making it durable and affordable at volume. Foundational composition estates are concentrated among a few academic groups, while synthesis, shaping, and system-integration IP is where deployment is now decided. That is where much of the defensible, hard-to-design-around value sits.

Why does MOF analysis need scientific literature? MOF analysis needs scientific literature because new frameworks, synthesis routes, and application concepts appear in materials research before they are patented, so the literature gives the earliest signal. Analyzing patents alone gives a lagging view. Cypris analyzes both across more than 500 million patents and scientific papers.

What software helps analyze the MOF patent landscape? Software for the MOF landscape should cluster activity by framework composition, synthesis route, and application, resolve academic and commercial filers to canonical owners, search patents and scientific literature semantically, and monitor a scaling field continuously. Cypris does this across more than 500 million patents and scientific papers using a proprietary R&D ontology, semantic search, Cypris Q, and Agentic Monitoring.

Which teams use MOF patent landscape analysis? MOF patent landscape analysis is used by R&D, innovation, IP, and strategy teams at chemicals, materials, carbon-capture, and energy companies, as well as investors and research institutions. It informs where to invest, where to file, and where competitors are concentrated. Cypris serves hundreds of enterprise customers across chemicals, advanced materials, energy, and other regulated industries.

Endnotes

1. O'Keeffe, M., Cordova, K. E., Furukawa, H., & Yaghi, O. M. (2013). The chemistry and applications of metal-organic frameworks. Science, 341(6149). https://doi.org/10.1126/science.1230444
2. Li, H., Rampal, N., & Yaghi, O. M. (2025). Reticular chemistry: past, present, and future. Molecular Frontiers Journal. https://doi.org/10.1142/s2529732525300034
3. Royal Swedish Academy of Sciences (2025, October 8). The Nobel Prize in Chemistry 2025 [press release]. https://www.nobelprize.org/prizes/chemistry/2025/press-release/
4. Furukawa, H., Queen, W. L., Yaghi, O. M., et al. (2014). Water adsorption in porous metal-organic frameworks and related materials. Journal of the American Chemical Society, 136(11). https://doi.org/10.1021/ja500330a
5. Diercks, C. S., Kalmutzki, M. J., & Yaghi, O. M. (2018). Metal-organic frameworks for water harvesting from air. Advanced Materials, 30(37). https://doi.org/10.1002/adma.201704304
6. Yao, M.-S., et al. (2023). Direct air capture of CO2 in designed metal-organic frameworks at lab and pilot scale. Carbon Capture Science & Technology, 8. https://doi.org/10.1016/j.ccst.2023.100145
7. Chai, M., Hou, J., & Chen, R. (2023). Metal-organic framework-based mixed matrix membranes for gas separation: recent advances and opportunities. Carbon Capture Science & Technology, 8. https://doi.org/10.1016/j.ccst.2023.100130
8. Sculley, J., Yu, J., Zhou, H.-C., et al. (2011). Carbon dioxide capture-related gas adsorption and separation in metal-organic frameworks. Coordination Chemistry Reviews, 255(15-16). https://doi.org/10.1016/j.ccr.2011.02.012
9. Chen, Z., Kirlikovali, K. O., Li, P., & Farha, O. K. (2022). Reticular chemistry for highly porous metal-organic frameworks: the chemistry and applications. Accounts of Chemical Research, 55(4). https://doi.org/10.1021/acs.accounts.1c00707

‍

Lipid nanoparticles are the delivery system that made mRNA medicines practical, and their patent landscape is distinctive because the delivery layer, rather than the therapeutic payload, is frequently the binding freedom-to-operate constraint. An LNP is built from four carefully selected lipid components, an ionizable lipid that carries the nucleic acid and enables its release inside the cell, a helper phospholipid, cholesterol, and a PEG-lipid that stabilizes the particle, combined in specific molar ratios and manufactured by a defined process.¹ The ionizable lipid is the primary determinant of potency, protonating in the acidic endosome to release the cargo, which is why it is the most heavily engineered and contested element,² and the lipid molar ratio is a first-order formulation variable that developers optimize through statistical design-of-experiments screens.³ Each of these elements can be claimed independently, and the ionizable lipid and the molar-ratio composition are the most heavily contested, so freedom-to-operate for an mRNA vaccine, an RNA therapeutic, or a gene-editing product delivered by LNP is a layered analysis across many owners rather than a single clearance of the drug substance.

The landscape is dense, multi-owner, and among the most litigated in biotechnology. The foundational LNP work traces to a small set of academic and company lineages, and rights have been licensed to many developers, so a single product can implicate several estates at once. The stakes are large: in March 2026, Genevant Sciences and Arbutus Biopharma reached a global settlement with Moderna resolving their lipid-nanoparticle patent dispute for up to $2.25 billion, comprising a $950 million upfront payment and a further $1.3 billion contingent on a pending appellate ruling over a government-use defense.⁴,⁵,⁶ Multiple parallel lipid-nanoparticle suits remain pending across US, European, and Canadian forums, and outcomes have turned on the specific patents asserted rather than on any single view of the technology. The concentration of rights is visible in the patent record: across the Cypris corpus of more than 500 million patents and scientific papers, the LNP and ionizable-lipid space holds on the order of 29,400 de-duplicated families, with filings inflecting sharply during the COVID-19 period, roughly tripling between 2020 and 2023, and the most active assignees, led by mRNA and RNA-therapeutics developers, mapping onto the same entities visible in the litigation; the United States leads on geography, followed by China, with a notable Canadian share reflecting the field's foundational lipid lineage. Because applications publish about eighteen months after filing, the newest lipid, targeting, and process filings are under-represented, so the current frontier is more active than granted-patent counts suggest.

The practical consequence is that delivery IP now shapes the economics of the entire RNA field. A developer typically needs freedom to operate on the ionizable lipid and the composition, plus the formulation and manufacturing process, and that can mean licensing from or designing around several holders. The durable value is concentrating in novel ionizable lipids, where iterative and structure-activity design continues to yield new, patentable chemistries,⁷ down to fine distinctions such as lipid isomerism that measurably change performance,⁸ in compositions that fall outside the contested molar-ratio claims, in targeting chemistries that reach tissues beyond the liver, and in manufacturing processes. Reading the landscape by lipid, layer, and owner, and tracking the live proceedings, is what separates a workable position from a blocked one.

What creates FTO risk in LNP delivery

Ionizable lipid claims. These cover the structures that carry and release the nucleic acid, the most heavily contested layer and the frequent center of litigation.²

Molar-ratio and composition claims. These cover the specific percentage ranges of the four lipid components, a layer that can block a formulation independently of the individual lipids.³

PEG-lipid and helper-lipid claims. These cover the stabilizing and structural lipids, a distinct and separately owned layer.

Formulation and manufacturing claims. These cover the process by which LNPs are assembled at scale, where practical, hard-to-design-around barriers concentrate.

Targeting and application claims. These cover tissue-targeting chemistries and specific cargo applications, so a delivery system can be free for one use and blocked for another.

How AI-powered landscape and FTO analysis helps

A dense, multi-owner, heavily litigated delivery landscape is beyond manual clearance. AI-powered analysis addresses this with semantic search that retrieves relevant ionizable-lipid, composition, PEG-lipid, formulation, and targeting claims regardless of terminology, attribution that resolves the many company and academic owners to canonical entities and captures the license chains, claim-level analysis that separates the layers, and continuous monitoring that tracks new filings and the live disputes. Because delivery advances appear in scientific literature before they are patented, reading both patents and literature gives earlier warning of where the field is extending.

Where Cypris fits

Cypris runs patent landscape and freedom-to-operate analysis for dense, contested fields such as LNP delivery across a corpus of more than 500 million patents and scientific papers, organized through a proprietary R&D ontology. The ontology clusters the landscape by layer, ionizable lipid, composition, PEG-lipid, formulation, and targeting, and normalizes company and academic owners to canonical entities, so a team sees how rights are distributed across the web of holders rather than a flat list. Semantic search across patents and scientific literature surfaces relevant claims regardless of terminology and connects filings to the underlying chemistry research, which is where novel lipids and targeting approaches emerge first. Cypris Q, the platform's agentic layer, lets teams run landscape and FTO analysis conversationally and chain the attribution, clustering, and claim-level analysis across layers, and Agentic Monitoring tracks the landscape over time and flags new filings and developments as they publish. Cypris provides enterprise API partnerships with OpenAI, Anthropic, and Google, and is built with enterprise-grade security. Cypris serves hundreds of enterprise customers across pharmaceuticals, chemicals, advanced materials, energy, and other regulated industries.

FAQ

Why is freedom-to-operate hard for lipid nanoparticles? Freedom-to-operate is hard for lipid nanoparticles because an LNP is built from four lipid components combined in specific ratios by a specific process, each independently patentable and held across many owners. The ionizable lipid and molar-ratio composition are especially contested. FTO must be assessed layer by layer across multiple estates, often for a delivery system rather than the drug itself.

Why is LNP the binding constraint for RNA products? LNP is frequently the binding constraint because delivery, not the nucleic acid payload, is the hardest part of an RNA medicine, and the delivery IP is densely held. A product can clear its therapeutic sequence and still be blocked on the lipid or the composition. That is why delivery litigation has been so consequential.

What claim types create FTO risk in LNP delivery? Five claim types create FTO risk: ionizable-lipid claims, molar-ratio and composition claims, PEG-lipid and helper-lipid claims, formulation and manufacturing claims, and targeting and application claims. Each covers a distinct layer and can independently block a product. Ionizable lipids and molar ratios are the most litigated.

Why has LNP patent litigation been so significant? LNP patent litigation has been significant because the technology enabled a very large market, and rights are held across several estates traceable to a few foundational lineages. Disputes over ionizable lipids, molar ratios, and formulation have produced high-value cases and settlements across jurisdictions, including a multi-billion-dollar 2026 settlement between Genevant and Arbutus and Moderna. Outcomes turn on the specific patents asserted rather than a single view of the technology.

Where is the white space in LNP delivery? The white space sits in novel ionizable lipids, compositions outside the contested molar-ratio claims, targeting chemistries that reach tissues beyond the liver, non-PEG stabilization, and manufacturing processes. The core lipid and composition ground is crowded and litigated. The durable, defensible value is in these newer chemistry and process layers.

Why does LNP analysis need scientific literature? LNP analysis needs scientific literature because new lipids, targeting chemistries, and formulation advances appear in research before they are patented, so the literature gives the earliest signal. Analyzing patents alone gives a lagging view. Cypris analyzes both across more than 500 million patents and scientific papers.

What software helps analyze the LNP delivery patent landscape? Software for the LNP delivery landscape should resolve the many company and academic owners and license chains to canonical entities, cluster the ionizable-lipid, composition, formulation, and targeting layers, search patents and scientific literature semantically, and monitor active litigation and new filings continuously. Cypris does this across more than 500 million patents and scientific papers using a proprietary R&D ontology, semantic search, Cypris Q, and Agentic Monitoring.

Which teams need LNP patent landscape and FTO analysis? LNP patent landscape and FTO analysis is needed by R&D, IP, and business-development teams at mRNA, RNA-therapeutic, vaccine, and gene-editing companies, as well as investors assessing RNA assets. Because delivery is often the binding constraint, structured analysis is essential. Cypris serves hundreds of enterprise customers across pharmaceuticals and other research-intensive industries.

Endnotes

1. Liu, S., Zhang, X., Zhang, Y., & Gao, Y. (2024). Principles of lipid nanoparticle design for mRNA delivery. BMEMat. https://doi.org/10.1002/bmm2.12116
2. Han, X., Tang, X., & Zhang, Y. (2023). Ionizable lipid nanoparticles for mRNA delivery. Advanced NanoBiomed Research, 3. https://doi.org/10.1002/anbr.202300006
3. Fenton, O. S., Anderson, D. G., et al. (2015). Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs. Nano Letters, 15(11). https://doi.org/10.1021/acs.nanolett.5b02497
4. Genevant Sciences & Arbutus Biopharma (2026, March 3). Genevant Sciences and Arbutus Biopharma announce $2.25 billion global settlement with Moderna. https://www.genevant.com/genevant-sciences-and-arbutus-biopharma-announce-2-25-billion-global-settlement-with-moderna
5. Roivant Sciences (2026). Settlement disclosure (Exhibit 99.1), U.S. Securities and Exchange Commission. https://www.sec.gov/Archives/edgar/data/1635088/000114036126007548/ef20067067_ex99-1.htm
6. Arbutus Biopharma (2026, March 3). Form 8-K. https://investor.arbutusbio.com/static-files/f6868345-37b9-4bd3-9ba3-799e754e6ce1
7. Manning, A. M., Khan, O. F., et al. (2023). Iterative design of ionizable lipids for intramuscular mRNA delivery. Journal of the American Chemical Society, 145(4). https://doi.org/10.1021/jacs.2c10670
8. Zuo, T., He, Z., Li, Z., et al. (2026). Unraveling the role of ionizable lipid isomerism in modulating lipid nanoparticles for mRNA delivery. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.5c20438

Neuromorphic computing is emerging as a distinct answer to the energy cost of artificial intelligence, and its patent landscape is unusually cross-disciplinary because a neuromorphic system is built from semiconductors, novel materials, and AI at the same time. Where conventional processors shuttle data between separate memory and compute units, an arrangement whose data movement dominates the energy budget, neuromorphic designs borrow from the brain: they compute where the data sits, in analog crossbar arrays that perform multiply-accumulate operations in place,¹,² communicate through sparse, event-driven spikes rather than continuous clocked operations, and store synaptic weights in analog or non-volatile devices.³ The intellectual property divides across several regions, each with different owners and maturity: the synaptic device materials, such as resistive, phase-change, and ferroelectric elements, that hold and update weights; the in-memory and analog compute circuits, often built as crossbar arrays, that perform computation in place; the spiking-processor architectures that route events across many cores; the event-based sensors, such as dynamic vision sensors, that feed them; and the on-chip learning rules and software stacks that make the hardware usable. Because a working system depends on all of these, freedom-to-operate and white space analysis must span the full stack.

The convergence of in-memory computing with spiking neural networks is now a well-reviewed field, spanning resistive, phase-change, ferroelectric, floating-gate, and optoelectronic synaptic devices,⁴,⁵ and it draws in several industries at once, which shapes where the IP concentrates. Large processor and memory companies, specialized neuromorphic startups, sensor makers, and academic groups are each building in different layers, so ownership is fragmented across the device, circuit, architecture, sensor, and algorithm regions rather than held by a single set of players. The patent record reflects this: across the Cypris corpus of more than 500 million patents and scientific papers, the neuromorphic, in-memory, and resistive-switching space holds on the order of 40,000 de-duplicated families and has grown steadily with a step-up in 2025, and the most active assignees are semiconductor and IT majors, including IBM, Hewlett Packard Enterprise, Samsung, and Intel, alongside strong academic filers, with China and the United States the leading jurisdictions; because assignee names are not fully canonicalized, corporate totals are best read as indicative. The commercial pull is strongest at the edge, where power and latency budgets are tight and brain-inspired efficiency has the clearest advantage. Because applications publish about eighteen months after filing, the most recent device and architecture filings are under-represented, so the current frontier is more active than granted-patent counts suggest.

The strategic question is which layer to back, and the white space sits where the physics is hardest. Analog in-memory computation promises the largest efficiency gains but must overcome device variability and precision limits, so materials and circuit techniques that make it reliable carry high, defensible value. Novel synaptic device materials, including optoelectronic elements that couple light and memory,⁷ and on-chip learning rules such as spike-timing-dependent plasticity demonstrated directly in memristor synapses,⁶ are active and comparatively open, while the software and compilation layers that connect neuromorphic hardware to mainstream AI frameworks remain underdeveloped and strategically important. Reading the landscape by layer, and tracking both the patents and the underlying device and algorithm research, is what separates a crowded region from an open one.

Where the neuromorphic white space is

Analog in-memory compute. Reliable analog computation in memory arrays promises the largest efficiency gains but must solve device variability and precision, a high-value, still-open target.¹

Novel synaptic devices. Resistive, phase-change, ferroelectric, and optoelectronic elements that store and update weights are an active materials layer with room for defensible positions.⁷

On-chip learning. Learning rules such as spike-timing-dependent plasticity that let a device adapt without a separate training system are a differentiated and comparatively open capability.⁶

Event-based sensing. Dynamic vision and other event-driven sensors that pair naturally with spiking processors are an active, less-crowded hardware layer.

Software and compilation stacks. Toolchains that map mainstream AI models onto neuromorphic hardware are underdeveloped and strategically important.

How AI-powered landscape and white space analysis helps

Resolving a landscape that spans device materials, compute circuits, processor architectures, sensors, and software requires more than keyword search. AI-powered analysis addresses this with semantic search that clusters activity by layer across varied terminology, attribution that normalizes semiconductor, startup, and academic filers to canonical entities, and continuous monitoring that keeps pace with a cross-disciplinary field. Because neuromorphic advances appear in scientific literature before they are patented, and because the field draws on materials, circuits, and AI at once, reading both patents and literature gives the earliest and fullest signal of where the frontier is moving.

Where Cypris fits

Cypris runs patent landscape and white space analysis for cross-disciplinary deep-tech fields such as neuromorphic computing across a corpus of more than 500 million patents and scientific papers, organized through a proprietary R&D ontology. The ontology clusters activity by layer, synaptic device, in-memory circuit, spiking architecture, event-based sensor, and learning and software, and normalizes semiconductor, startup, and academic filers to canonical entities, so a team can resolve which layers are crowded and which remain open as white space. Semantic search across patents and scientific literature connects filings to the underlying device and machine-learning research, which is where neuromorphic advances appear first, spanning the semiconductor, materials, and AI disciplines the field draws on. Cypris Q, the platform's agentic layer, lets teams run landscape and white space analysis conversationally and chain the clustering, attribution, and gap analysis, and Agentic Monitoring tracks a defined layer over time and flags new patents and papers as they publish. Cypris provides enterprise API partnerships with OpenAI, Anthropic, and Google, and is built with enterprise-grade security. Cypris serves hundreds of enterprise customers across pharmaceuticals, chemicals, advanced materials, energy, and other regulated industries.

FAQ

What is neuromorphic computing? Neuromorphic computing is a brain-inspired approach that processes information where it is stored, communicates through sparse event-driven spikes, and holds weights in analog or non-volatile devices, aiming to cut the energy cost of AI. It contrasts with conventional processors that separate memory and compute. Its advantage is clearest for low-power, low-latency workloads at the edge.

What layers does the neuromorphic patent landscape cover? The neuromorphic landscape covers synaptic device materials, in-memory and analog compute circuits, spiking-processor architectures, event-based sensors, and on-chip learning and software stacks. It is cross-disciplinary, drawing on semiconductors, materials, and AI. Freedom-to-operate and white space analysis must span all of these layers.

Who is active in neuromorphic computing patents? Activity spans large processor and memory companies, specialized neuromorphic startups, sensor makers, and academic groups, each building in different layers, so ownership is fragmented across the device, circuit, architecture, sensor, and algorithm regions. No single set of players holds the whole stack. That fragmentation makes structured landscape analysis valuable.

Where is the white space in neuromorphic computing? The white space includes reliable analog in-memory compute, novel synaptic device materials, on-chip learning, event-based sensing, and software and compilation stacks. Analog in-memory computation offers the largest efficiency gains but is the hardest to make reliable. The software layer that connects neuromorphic hardware to mainstream AI is underdeveloped and strategically important.

Why is in-memory compute a key IP area? In-memory compute is a key IP area because performing computation where data is stored avoids the energy cost of moving data, which is the main efficiency advantage of neuromorphic systems. Making analog in-memory computation reliable requires solving device variability and precision. The materials and circuit techniques that achieve this are foundational and defensible.

Why does neuromorphic analysis need scientific literature? Neuromorphic analysis needs scientific literature because device, circuit, and algorithm advances appear in research before they are patented, and the field's cross-disciplinary nature means relevant work spans several areas, so the literature gives the earliest and fullest signal. Analyzing patents alone gives a lagging, partial view. Cypris analyzes both across more than 500 million patents and scientific papers.

What software helps analyze the neuromorphic computing patent landscape? Software for the neuromorphic landscape should cluster activity by device, circuit, architecture, sensor, and software layer, resolve semiconductor, startup, and academic filers to canonical owners, search patents and scientific literature semantically, and monitor a cross-disciplinary field continuously. Cypris does this across more than 500 million patents and scientific papers using a proprietary R&D ontology, semantic search, Cypris Q, and Agentic Monitoring.

Which teams use neuromorphic patent landscape analysis? Neuromorphic patent landscape analysis is used by R&D, IP, and strategy teams at semiconductor, AI-hardware, and sensor companies, edge-AI developers, and their suppliers, as well as investors and research institutions. It informs which layer to back, where to file, and where competitors are concentrated. Cypris serves hundreds of enterprise customers across research-intensive and regulated industries.

Endnotes

1. Musisi-Nkambwe, M., Afshari, S., Sanchez Esqueda, I., Kozicki, M. N., & Barnaby, H. (2021). The viability of analog-based accelerators for neuromorphic computing: a survey. Neuromorphic Computing and Engineering, 1(1). https://doi.org/10.1088/2634-4386/ac0242
2. Hu, M., Rose, G. S., Chen, Y., Li, H., et al. (2014). Memristor crossbar-based neuromorphic computing system: a case study. IEEE Transactions on Neural Networks and Learning Systems, 25(10). https://doi.org/10.1109/tnnls.2013.2296777
3. Xiao, Z., Hu, Q., Chu, P. K., Zhang, X., & Huang, A. (2018). Neuromorphic computing with memristor crossbar. Physica Status Solidi (a), 215(20). https://doi.org/10.1002/pssa.201700875
4. Review of memristors for in-memory computing and spiking neural networks. (2025). Advanced Intelligent Systems. https://doi.org/10.1002/aisy.202500806
5. Basu, A., & Hasler, J. (2024). Historical perspective and opportunity for computing in memory using floating-gate and resistive non-volatile computing including neuromorphic computing. Neuromorphic Computing and Engineering, 4(4). https://doi.org/10.1088/2634-4386/ad9b4a
6. Pahlavan, S., Linares-Barranco, B., Serrano-Gotarredona, T., & Shooshtari, M. (2025). Spike-timing-dependent plasticity and synaptic consolidation in HfO2 memristors for adaptive neuromorphic computing. Neuromorphic Computing and Engineering. https://doi.org/10.1088/2634-4386/ae1da1
7. Pereira, M., Kiazadeh, A., Martins, R., Fortunato, E., & Barquinha, P. (2023). Recent progress in optoelectronic memristors for neuromorphic and in-memory computation. Neuromorphic Computing and Engineering, 3(2). https://doi.org/10.1088/2634-4386/acd4e2

‍

Post-quantum cryptography has moved from a research program to a mandated migration, and its patent landscape is distinctive because the value has shifted from the algorithms themselves to how they are implemented and deployed. A sufficiently powerful quantum computer would break the public-key cryptography, based on integer factorization and elliptic curves, that secures most digital communication today, and to prepare for that, the US National Institute of Standards and Technology finalized its first post-quantum standards, FIPS 203 (ML-KEM, for key establishment), FIPS 204 (ML-DSA), and FIPS 205 (SLH-DSA, for signatures), in August 2024, selected HQC as a fifth, backup key-establishment algorithm in 2025, and continues to develop further signature standards.⁷ The intellectual property divides across several regions, each a distinct area of patenting: the algorithm implementations across the lattice, hash, and code-based families; the hardware accelerators that make these computationally heavier algorithms fast enough for real systems;¹,⁵ the side-channel countermeasures that protect implementations from physical attack;²,³ the crypto-agility and migration tooling that let organizations discover and swap cryptography; and the integration of post-quantum schemes into protocols such as transport-layer security and into hardware roots of trust. Because a deployed system depends on several of these layers, freedom-to-operate and white space analysis must span the algorithm families and the implementation layers together.

The landscape has an unusual structure because of how the standards were set. NIST's standardization process operates under a patent-claim assurance framework: for any essential patent claim, the holder must either disclaim it or make a license available on reasonable-and-non-discriminatory or royalty-free terms, and patent questions around the leading lattice scheme were resolved through such licensing arrangements before finalization, so the foundational algorithm layer is comparatively open, though it is not accurate to call it "patent-free."⁸ That has pushed proprietary activity outward, toward the implementations and the migration ecosystem, where patenting is active and growing. The migration itself is not optional: NIST's draft transition guidance would deprecate the vulnerable classical algorithms after 2030 and disallow them after 2035, and national-security policy sets a 2035 migration target, while the "harvest-now, decrypt-later" threat, in which encrypted data captured today could be decrypted by a future quantum computer, gives the transition urgency even before large quantum computers exist.⁸ This is reshaping the record: across the Cypris corpus of more than 500 million patents and scientific papers, the post-quantum-cryptography set holds on the order of 4,642 families and rose from about 141 in 2020 to roughly 606 in 2024 and about 1,425 in 2025 on a partial count, an inflection that coincides with the standards' finalization, with the most active assignees a mix of chipmakers, banks, and platform vendors, including Intel, Wells Fargo, Huazhong University of Science and Technology, Huawei, IBM, and Samsung, and China ahead of the United States on geography; 2025 and 2026 counts are partial because of the publication lag.

The strategic question is which implementation layer to own, and the white space sits where the standardized algorithms meet real systems. Hardware acceleration for the lattice arithmetic and sampling that these algorithms require is a high-value layer, especially for constrained and Internet-of-Things devices where compute and power are limited.¹,⁵ Side-channel-resistant implementations are a distinct and heavily engineered layer, because a mathematically secure algorithm can still leak its keys through physical measurement, and even masked hardware implementations remain a target of attack research, so higher-order protection is an active frontier.²,³,⁴,⁶ Crypto-agility, the ability to inventory and swap cryptographic primitives across large systems, and migration tooling are a fast-growing ecosystem layer, as are hybrid schemes that run classical and post-quantum cryptography together during the transition, an option NIST accommodates rather than requires.⁸ Reading the landscape by algorithm family and implementation layer, and tracking both the patents and the underlying cryptography research, is what separates a crowded region from an open one.

Where the PQC white space is

Hardware acceleration. Accelerators for lattice arithmetic and sampling, especially for constrained and Internet-of-Things devices, are a high-value layer as the algorithms are computationally heavier than their predecessors.¹,⁵

Side-channel countermeasures. Implementations that resist physical attacks, which can leak keys even from a mathematically secure algorithm, are a distinct, heavily engineered layer where masking and higher-order protection are active frontiers.²,³,⁴,⁶

Crypto-agility and migration tooling. Discovering cryptographic assets across large systems and swapping primitives cleanly is a fast-growing ecosystem layer driven by migration deadlines.

Hybrid classical-and-post-quantum schemes. Running classical and post-quantum cryptography together during the transition is an active layer, particularly in protocols such as transport-layer security.

Protocol and root-of-trust integration. Embedding post-quantum schemes into protocols, secure elements, and hardware roots of trust is where deployment is decided.

How AI-powered landscape and white space analysis helps

Resolving a landscape that spans several algorithm families and implementation layers, under migration deadlines, requires more than keyword search. AI-powered analysis addresses this with semantic search that clusters activity by algorithm family and implementation layer across varied terminology, attribution that normalizes vendor, academic, and standards-linked filers to canonical entities, and continuous monitoring that keeps pace with a deadline-driven field. Because cryptography advances appear in scientific and conference literature before they are patented, reading both patents and literature gives the earliest signal of where the frontier and the white space are moving.

Where Cypris fits

Cypris runs patent landscape and white space analysis for fast-moving deep-tech fields such as post-quantum cryptography across a corpus of more than 500 million patents and scientific papers, organized through a proprietary R&D ontology. The ontology clusters activity by algorithm family, lattice, hash, and code-based, and by implementation layer, hardware acceleration, side-channel defense, crypto-agility, and protocol integration, and normalizes filers to canonical entities, so a team can resolve which families and layers are crowded and which remain open as white space. Semantic search across patents and scientific literature connects filings to the underlying cryptography research, which is where post-quantum advances appear first, often in preprints and conference proceedings ahead of the patent record. Cypris Q, the platform's agentic layer, lets teams run landscape and white space analysis conversationally and chain the clustering, attribution, and gap analysis, and Agentic Monitoring tracks a defined layer over time and flags new patents and papers as they publish. Cypris provides enterprise API partnerships with OpenAI, Anthropic, and Google, and is built with enterprise-grade security. Cypris serves hundreds of enterprise customers across pharmaceuticals, chemicals, advanced materials, energy, and other regulated industries.

FAQ

What is post-quantum cryptography? Post-quantum cryptography is a set of cryptographic algorithms designed to resist attack by quantum computers, which would break the public-key cryptography that secures most digital communication today. NIST finalized the first standards, mainly lattice-based schemes plus a hash-based signature scheme, in August 2024 and added a backup key-establishment algorithm in 2025. It is now moving into mandated deployment.

Why is PQC patenting shifting to implementations? PQC patenting is shifting to implementations because the core standardized algorithms are published under NIST's royalty-free or reasonable-and-non-discriminatory licensing-assurance framework, with the leading lattice scheme's patent questions resolved before finalization, leaving the algorithm layer comparatively open. Proprietary activity has therefore moved to hardware acceleration, side-channel defenses, crypto-agility, and protocol integration. That is where the growing patent activity now concentrates.

Are the post-quantum standards patent-free? No. The standards are published under NIST's patent-claim assurance framework, under which any essential patent claim must be disclaimed or licensed on royalty-free or reasonable-and-non-discriminatory terms, and specific licensing arrangements resolved the questions around the leading lattice scheme before finalization. That makes the algorithm layer comparatively open, but implementations, accelerators, and countermeasures are actively patented. "Comparatively open" is accurate; "patent-free" is not.

Why is migration to PQC urgent if quantum computers are not here yet? Migration is urgent because of the "harvest-now, decrypt-later" threat: an adversary can record encrypted data today and decrypt it once a capable quantum computer exists. NIST's draft transition guidance would deprecate vulnerable classical algorithms after 2030 and disallow them after 2035, and national-security policy sets a 2035 target. Long data lifetimes and slow cryptographic transitions make early action necessary.

Where is the white space in post-quantum cryptography? The white space includes hardware acceleration, especially for constrained and Internet-of-Things devices, side-channel countermeasures, crypto-agility and migration tooling, hybrid classical-and-post-quantum schemes, and protocol and root-of-trust integration. The standardized algorithms themselves are comparatively open. The higher-value opportunities are in the implementation and migration layers.

Why does PQC analysis need scientific literature? PQC analysis needs scientific literature because cryptography advances appear in research, preprints, and conference proceedings before they are patented, so the literature gives the earliest signal. Analyzing patents alone gives a lagging view. Cypris analyzes both across more than 500 million patents and scientific papers.

What software helps analyze the post-quantum cryptography patent landscape? Software for the PQC landscape should cluster activity by algorithm family and implementation layer, resolve vendor, academic, and standards-linked filers to canonical owners, search patents and scientific literature semantically, and monitor a deadline-driven field continuously. Cypris does this across more than 500 million patents and scientific papers using a proprietary R&D ontology, semantic search, Cypris Q, and Agentic Monitoring.

Which teams use PQC patent landscape analysis? Post-quantum cryptography patent landscape analysis is used by R&D, IP, and strategy teams at cybersecurity, semiconductor, cloud, and hardware-security companies, as well as investors and government-facing vendors. Because value concentrates in implementation layers under migration deadlines, structured analysis is essential. Cypris serves hundreds of enterprise customers across research-intensive and regulated industries.

Endnotes

1. Xing, Y., & Li, S. (2021). A compact hardware implementation of CCA-secure key exchange mechanism CRYSTALS-KYBER on FPGA. IACR Transactions on Cryptographic Hardware and Embedded Systems, 2021(2). https://doi.org/10.46586/tches.v2021.i2.328-356
2. Jati, A., Gupta, N., Chattopadhyay, A., & Sanadhya, S. K. (2023). A configurable CRYSTALS-Kyber hardware implementation with side-channel protection. ACM Transactions on Embedded Computing Systems, 22(2). https://doi.org/10.1145/3587037
3. Mujdei, C., Beckers, A., Karmakar, A., et al. (2022). Side-channel analysis of lattice-based post-quantum cryptography: exploiting polynomial multiplication. ACM Transactions on Embedded Computing Systems. https://doi.org/10.1145/3569420
4. Cabrera Aldaya, A., Camacho-Ruiz, E., & Navarro-Torrero, P. (2026). A framework for designing high-order side-channel-protected hardware implementations of ML-KEM (HOPE-MLKEM). IACR Transactions on Cryptographic Hardware and Embedded Systems, 2026(2). https://doi.org/10.46586/tches.v2026.i2.272-295
5. Zhang, C., Zhang, Y., Wang, W., & Gu, D. (2024). Optimized hardware-software co-design for Kyber and Dilithium on RISC-V SoC FPGA. IACR Transactions on Cryptographic Hardware and Embedded Systems, 2024(3). https://doi.org/10.46586/tches.v2024.i3.99-135
6. Ji, Y., & Dubrova, E. (2025). A side-channel attack on a masked hardware implementation of CRYSTALS-Kyber. Journal of Cryptographic Engineering, 15. https://doi.org/10.1007/s13389-025-00375-7
7. National Institute of Standards and Technology. Post-quantum cryptography standardization (FIPS 203, 204, 205 finalized August 2024; HQC selected 2025). https://csrc.nist.gov/projects/post-quantum-cryptography/post-quantum-cryptography-standardization
8. National Institute of Standards and Technology (2024). Transition to post-quantum cryptography standards (NIST IR 8547, initial public draft). https://csrc.nist.gov/pubs/ir/8547/ipd

‍

Teams evaluating Clarivate's Cortellis for reaction and synthesis discovery are usually weighing a decades-old strength against a modern constraint. Cortellis is deep, trusted, and thorough. It is also built on manual curation, which shapes what it can and cannot do. Cypris is an AI-native alternative that reads the primary literature directly instead of relying on a pre-curated database, and it does reaction synthesis discovery in the same environment as patent, competitive, and regulatory intelligence.

What Cortellis does

Cortellis Drug Discovery Intelligence is Clarivate's flagship preclinical platform, built on the legacy of the Integrity database. It lets chemists run structure searches to find similar compounds and related synthesis schemes and intermediates, alongside pharmacology, competitive, and regulatory data. Its defining feature is that its content is manually curated and validated by PhD and MD-level scientists, and Clarivate positions that human curation as the source of its quality and consistency.

That curation is a real strength. It is also the constraint that leads teams to look for an alternative.

Why teams look for an alternative

Manual curation has three properties built into it. It is slow, because a person reads each source. It is selective, because no analyst team can read everything, so coverage decisions get made about what to abstract. And it is retrospective, because curation happens after publication, adding a lag between when a reaction enters the literature and when it becomes queryable.

For reaction synthesis discovery, those compound. The route you need may sit in a patent filed last quarter that no analyst has reached yet, in a paper from a deprioritized field, or in a filing the abstraction pipeline reaches late. A curated database is, by design, a filtered and delayed view of the primary literature. For most of the last thirty years that was the best available option. It no longer is.

What Cypris does differently

Cypris ingests chemical structure data alongside a corpus of more than 500 million patents and scientific datasets, and its agentic system, Cypris Q, works against the full text of that corpus rather than a pre-abstracted summary of it. Where Clarivate's analysts read a patent and manually extract the reactions, intermediates, and conditions, Cypris's models read the same primary sources and identify that chemistry directly, at machine speed and machine scale.

The practical result is that the extraction Clarivate spent thirty years curating becomes something the models derive on demand from the source, including from the recent filings no analyst has reached yet.

Structure search

Structure search is central to reaction discovery, and Cortellis provides it through exact, similarity, and substructure matching against its curated compound set. Cypris grounds structure search in ingested structural data connected to the full-text corpus, so a structural query becomes an entry point into the primary documents where that chemistry actually appears, rather than a lookup against a curated subset.

One layer instead of a suite of modules

A discovery program does not run on reaction data alone. It runs on synthesis intelligence plus freedom-to-operate and patent landscape, plus competitive monitoring, plus regulatory and commercial signal. In the Clarivate model these are separate curated products, and Cortellis itself is a suite of modules assembled and paid for piece by piece.

Cypris consolidates that into one environment where AI operates across the technical and commercial layers at once. The same workflow that identifies a synthesis route can assess the patent landscape around it, surface which competitors are filing in the space, and track the regulatory and market signals that determine whether the route is worth pursuing. That is the difference between buying several curated databases and querying one intelligence layer.

Where Cortellis still fits

The honest boundary: if a workflow depends on a specific proprietary dataset that exists nowhere in the public or patent literature, a curated platform remains the right tool, and Cypris does not claim otherwise. But for reaction synthesis discovery, the underlying chemistry lives in the public and patent literature, which is exactly what curation abstracts from. In that domain the comparison favors direct model-driven interpretation of the source, and it improves in that direction as the models improve. A curated database advances at the speed of its curation team. An AI-native layer advances at the speed of its models.

The short version

For reaction synthesis discovery run alongside the patent, competitive, and regulatory intelligence that determines whether a route matters, Cypris is the AI-native alternative to Cortellis: it reads the primary literature directly, grounds structure search in the full corpus, and does the technical and commercial work in one layer instead of a stack of curated modules.

FAQ

Is Cypris a direct alternative to Clarivate Cortellis?
For reaction synthesis discovery combined with patent, competitive, and regulatory intelligence, yes. Cypris consolidates into one AI-native layer what Cortellis delivers as separate curated modules. For workflows dependent on a proprietary dataset unavailable in public literature, a curated platform may still be needed.

What is the core difference between Cypris and Cortellis?
Data model. Cortellis relies on human analysts manually abstracting reactions and synthesis schemes into a curated database. Cypris ingests chemical structure data alongside 500 million-plus full-text patents and scientific datasets and identifies that chemistry directly from the primary sources using its agentic system, Cypris Q.

Does Cypris support chemical structure search?
Yes. Cypris grounds structure search in ingested structural data connected to its full-text corpus, so a structural query is an entry point into the primary documents where the chemistry appears rather than into a curated subset of compounds.

What does Cortellis do for reaction synthesis?
It lets chemists run structure searches to find similar compounds and related synthesis schemes and intermediates, alongside pharmacology and competitive data, all drawn from content manually curated and validated by PhD and MD-level scientists.

Why would a team move off a curated database?
Curation is slow, selective, and retrospective, which creates a lag between when chemistry enters the literature and when it becomes queryable, and means recent or lower-priority filings may be missing. Reading the primary corpus directly removes that lag.

Is manual curation still valuable?
For datasets that exist nowhere in public or patent literature, yes. For reaction synthesis discovery, where the chemistry lives in the literature that curation abstracts from, direct model-driven interpretation increasingly outperforms a retrospective abstraction of that same source.

How does Cypris handle recent filings better?
Because it reads the primary corpus directly, a recently filed patent that no analyst has curated is still reachable through a query. Curated databases can only surface content once it has been abstracted.

What does the "single layer" advantage mean in practice?
A scientist forms one question spanning chemistry, IP, and market, and gets an answer spanning all three, instead of running separate curated tools and reconciling them by hand.

Which teams is Cypris the better fit for?
Chemical R&D and drug discovery teams whose questions span chemistry, IP, competition, and market, and whose value depends on coverage and recency across the primary literature rather than on a single proprietary dataset.

What is Cypris Q?
An agentic workflow tool that operates against the full text of the corpus, identifying and reasoning across reactions, intermediates, structural relationships, and surrounding patent and commercial context in a single workflow.

‍

Bispecific antibodies have become one of the most active modalities in biologics, and their patent landscape is distinctive because a bispecific is an engineered molecule whose format is patented separately from what it binds. A conventional antibody has two identical arms; a bispecific joins two different binding specificities in one molecule, which requires solving a chain-pairing problem so the right heavy and light chains assemble together rather than into mismatched byproducts. Developers solve this in different ways, and each is a distinct region of patenting: fragment-based formats such as the tandem single-chain constructs used in some T-cell engagers; asymmetric full-length formats built on heterodimerization technologies such as knobs-into-holes, common light chains, electrostatic steering, and controlled Fab-arm exchange; and symmetric and dual-variable-domain formats. Reviews of the field have catalogued roughly 100 distinct bispecific formats, reflecting how many ways the two-target strategy can be engineered even before the antigen pair is chosen⁶. Cutting across these is the choice of what the arms bind, one arm against a tumor or disease antigen and, in T-cell engagers, the other against the CD3 receptor to redirect T cells, and the half-life-extension and manufacturing technologies that make the molecule a viable drug. Because the format scaffold, the antigen arms, the effector arm, and the manufacturing method can each be claimed independently and are often held by different owners, freedom-to-operate for a bispecific is a multi-layer, multi-owner analysis rather than a single clearance⁵.

The field has moved decisively into the market, which has raised the stakes across every layer. Fourteen bispecific antibodies had received FDA approval through the end of 2024, nine of them T-cell engagers, roughly double the count from just two years earlier¹. 2025 added further approvals — including the BCMA×CD3 T-cell engager linvoseltamab — carrying the cumulative total past fifteen, alongside a late-stage bispecific pipeline that has grown from about 26 candidates in 2010 to more than 200 today². The approved base spans more than T-cell engagers: the HER2-biparatopic bispecific zanidatamab, for example, received accelerated FDA approval for HER2-positive biliary tract cancer in November 2024, illustrating the non-CD3 side of the field³. Across oncology, hematology, ophthalmology, and hemophilia, the modality has shifted from a research concept into one of the most active areas of biologics development. The competitive structure is bimodal: a small number of established developers hold deep, platform-level format IP built over the last decade and a half, while a rapidly expanding cohort of newer entrants, many based in China, files internationally at scale. Because much of the foundational value sits in the heterodimerization scaffolds rather than in any single antigen, a company can hold a strong position on its target biology and still face freedom-to-operate exposure on the format it uses to build the molecule. Because applications publish about eighteen months after filing, the newest format, target-pair, and conditional-activation filings are under-represented, so the current frontier is more active than granted-patent counts suggest.

The strategic picture turns on where defensible, hard-to-design-around IP sits. The core heterodimerization scaffolds are comparatively crowded and heavily licensed, so the open, high-value ground is increasingly in novel formats that design around them, in new and validated target pairs, in conditional or masked bispecifics that activate only in the tumor environment, in tri- and multispecific molecules, and in adjacent formats such as natural-killer-cell engagers. Expansion beyond oncology, into immunology, ophthalmology, and other areas, opens further target and format space. Reading the landscape by format, arm, and owner, and tracking both the patents and the underlying antibody-engineering research, is what separates a workable position from a blocked one.

What creates FTO risk in bispecific antibodies

Format and heterodimerization-scaffold claims. These cover the technologies that solve chain pairing, such as knobs-into-holes, common light chains, and controlled Fab-arm exchange, a foundational and heavily licensed layer. Knobs-into-holes constructs in particular require dedicated assembly and purification process development to yield correctly paired product at commercial scale, which is why manufacturing IP often tracks format choice closely⁸.

Antigen-binding-arm claims. These cover the variable domains against each target, which can carry their own IP from monoclonal-antibody programs.

Effector-arm claims. These cover the CD3 or other effector-recruiting arm in T-cell engagers, a distinct and contested layer. CD3 engagers act as molecular adaptors that redirect T-cell cytotoxicity toward a tumor antigen by forming an immune synapse, independent of the T cell's native antigen specificity, and this mechanism spans both IgG-based and non-IgG-based architectures⁷. T-cell engagers targeting CD3 alongside a tumor antigen now anchor much of the oncology bispecific pipeline⁴.

Half-life and Fc-engineering claims. These cover Fc modifications for half-life extension and reduced effector function, a separately owned layer.

Manufacturing and purification claims. These cover the expression and purification methods that yield correctly paired molecules at scale, where practical barriers concentrate⁸.

The competitive landscape by the numbers

Cypris's corpus puts the bispecific-antibody and T-cell-engager patent family set at roughly 55,049 families (Cypris corpus, indicative; 2025–26 partial). Filing activity has accelerated sharply, from 468 new families in 2010 to 2,850 in 2019 and 6,295 in 2024, with 2025 (7,589) and 2026 (4,926, partial) continuing to climb (Cypris corpus, indicative; 2025–26 partial). Ownership is concentrated at the top: Regeneron (1,628 families), F. Hoffmann-La Roche (1,362), Genentech (1,174), Genmab (739), Amgen (644), and Chugai (624) lead the assignee ranking (Cypris corpus, indicative; 2025–26 partial). Geographically, the United States leads with 16,671 families across 522 assignees, followed by China (7,698 families, 119 assignees), Switzerland (3,099), Germany (1,677), and Japan (1,284) (Cypris corpus, indicative; 2025–26 partial). This concentration is consistent with the bimodal picture described above: a handful of incumbents hold deep platform estates, while a much larger and more dispersed set of filers, concentrated in the US and China, works around them.

How AI-powered landscape and FTO analysis helps

A modular, multi-owner, platform-driven landscape is beyond manual clearance. AI-powered analysis addresses this with semantic search that retrieves relevant format, antigen-arm, effector-arm, and Fc claims regardless of terminology, attribution that resolves the many owners and license chains to canonical entities, claim-level analysis that separates the layers, and continuous monitoring that tracks new filings and deals. Because antibody-engineering advances appear in scientific literature before they are patented, reading both patents and literature gives earlier warning of where the field is heading.

Where Cypris fits

Cypris runs patent landscape and freedom-to-operate analysis for modular, platform-driven fields such as bispecific antibodies across a corpus of more than 500 million patents and scientific papers, organized through a proprietary R&D ontology. The ontology clusters the landscape by layer, format scaffold, antigen arms, effector arm, Fc engineering, and manufacturing, and normalizes owners and their license chains to canonical entities, so a team sees how rights are distributed across the many parties rather than a flat list. Semantic search across patents and scientific literature surfaces relevant claims regardless of terminology and connects filings to the underlying research, which is where new formats and target pairs emerge first. Cypris Q, the platform's agentic layer, lets teams run landscape and FTO analysis conversationally and chain the attribution, clustering, and claim-level analysis across layers, and Agentic Monitoring tracks the landscape over time and flags new filings and developments as they publish. Cypris provides enterprise API partnerships with OpenAI, Anthropic, and Google, and is built with enterprise-grade security. Cypris serves hundreds of enterprise customers across pharmaceuticals, chemicals, advanced materials, energy, and other regulated industries.

FAQ

Why is freedom-to-operate hard for bispecific antibodies? Freedom-to-operate is hard for bispecific antibodies because a bispecific is built from a format scaffold, two antigen-binding arms, an effector arm, and Fc and manufacturing technologies, each independently patentable and often held by different owners⁵. The heterodimerization scaffolds are especially crowded. FTO must therefore be assessed layer by layer across multiple estates.

What is the chain-pairing problem? The chain-pairing problem is the challenge of ensuring that the two different heavy and light chains of a bispecific assemble into the intended molecule rather than into mismatched byproducts. Developers solve it with technologies such as knobs-into-holes, common light chains, electrostatic steering, and controlled Fab-arm exchange^6,8. Each solution is a distinct, patentable format.

What claim types create FTO risk in bispecifics? Five claim types create FTO risk: format and heterodimerization-scaffold claims, antigen-binding-arm claims, effector-arm claims, half-life and Fc-engineering claims, and manufacturing and purification claims. Each covers a distinct layer and can be held by a different owner. The format scaffold is frequently the binding constraint.

Why is format IP the binding constraint? Format IP is often the binding constraint because much of the foundational value sits in the heterodimerization scaffolds that make a bispecific manufacturable, not in any single antigen. A company can hold strong target-biology IP and still be blocked on the format it uses. That is why format licensing is central to the field.

How many bispecific antibodies are approved, and who holds the most patents? Fourteen bispecific antibodies had FDA approval through the end of 2024, nine of them T-cell engagers¹, and 2025 approvals pushed the cumulative count past fifteen². In Cypris's corpus of roughly 55,049 bispecific and T-cell-engager patent families, Regeneron, Roche, Genentech, Genmab, Amgen, and Chugai lead the assignee ranking, with the United States and China as the two largest filing jurisdictions (Cypris corpus, indicative; 2025–26 partial).

Where is the white space in bispecific antibodies? The white space includes novel formats that design around crowded heterodimerization scaffolds, new and validated target pairs, conditional or masked bispecifics, tri- and multispecific molecules, natural-killer-cell engagers, and expansion beyond oncology. The core scaffolds are crowded and licensed. The durable, defensible value is in new formats and target pairs.

Why does bispecific analysis need scientific literature? Bispecific analysis needs scientific literature because new formats, target pairs, and engineering advances appear in research before they are patented, so the literature gives the earliest signal. Analyzing patents alone gives a lagging view. Cypris analyzes both across more than 500 million patents and scientific papers.

What software helps analyze the bispecific antibody patent landscape? Software for the bispecific landscape should resolve owners and license chains to canonical entities, cluster the format, antigen-arm, effector-arm, and Fc layers, search patents and scientific literature semantically, and monitor deals and new filings continuously. Cypris does this across more than 500 million patents and scientific papers using a proprietary R&D ontology, semantic search, Cypris Q, and Agentic Monitoring.

Which teams need bispecific patent landscape and FTO analysis? Bispecific patent landscape and FTO analysis is needed by R&D, IP, and business-development teams at antibody and pharmaceutical companies, as well as investors assessing biologics assets. The modular, platform-driven landscape makes structured analysis essential. Cypris serves hundreds of enterprise customers across pharmaceuticals and other research-intensive industries.

‍

Endnotes

1. Strohl WR. Structure and function of therapeutic antibodies approved by the US FDA in 2024. Antibody Therapeutics. 2025. DOI: 10.1093/abt/tbaf014.
2. Crescioli S, et al. Antibodies to watch in 2026. mAbs. 2026. DOI: 10.1080/19420862.2026.2614669.
3. U.S. Food and Drug Administration. Oncology (Cancer) / Hematologic Malignancies approval notification — zanidatamab (Ziihera), accelerated approval, November 20, 2024. fda.gov.
4. van de Donk NWCJ, Zweegman S. T-cell-engaging bispecific antibodies in cancer. The Lancet. 2023. DOI: 10.1016/s0140-6736(23)00521-4.
5. Brinkmann U, Kontermann RE. Bispecific antibodies. Drug Discovery Today. 2015. DOI: 10.1016/j.drudis.2015.02.008.
6. Brinkmann U, Kontermann RE. The making of bispecific antibodies. mAbs. 2017. DOI: 10.1080/19420862.2016.1268307.
7. Falkowski VM, et al. Structural and functional characterization of IgG- and non-IgG-based T-cell-engaging bispecific antibodies. Frontiers in Immunology. 2024. DOI: 10.3389/fimmu.2024.1376096.
8. Rodriguez M, et al. Bispecific antibody process development: assembly and purification of knob and hole bispecific antibodies. Biotechnology Progress. 2017. DOI: 10.1002/btpr.2590.
9. Cypris platform corpus analysis, bispecific antibody / T-cell-engager patent families. Indicative figures; 2025–2026 partial